Polly Niravath

TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases

Rachel A. Freedman, Rebecca Gelman, Carey K. Anders et al. · Journal of Clinical Oncology · 2019 · 338 citations · Full text

Medicine, Oncology, Pharmacology +17

Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer

Julie R. Nangia, Tao Wang, Cynthia Osborne et al. · JAMA · 2017 · 229 citations

Medicine, Dermatology, Oncology +13

Neratinib Efficacy and Circulating Tumor DNA Detection of <i>HER2</i> Mutations in <i>HER2</i> Nonamplified Metastatic Breast Cancer

X. Cynthia, Ron Bose, Feng Gao et al. · Clinical Cancer Research · 2017 · 191 citations · Full text

Medicine, Oncology, Pharmacology +15

Lactadherin and clearance of platelet-derived microvesicles

Swapan Dasgupta, Hanan Abdel‐Monem, Polly Niravath et al. · Blood · 2008 · 190 citations · Full text

Medicine, Biochemistry, Biomaterials +3

Translational Breast Cancer Research Consortium (TBCRC) 022: A Phase II Trial of Neratinib for Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases

Rachel A. Freedman, Rebecca Gelman, Jeffrey S. Wefel et al. · Journal of Clinical Oncology · 2016 · 169 citations · Full text

Medicine, Oncology, Pharmacology +17